22 Recruiting Atopic Dermatitis Phase 2 Clinical Trials
Active phase 2 studies for atopic dermatitis enrolling across the USA. Verify eligibility and contact site coordinators.
All Atopic Dermatitis studiesPhase 2 Studies for Atopic Dermatitis
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
📍 Aclaris Clinical Site — Phoenix, Arizona
View Study & Checklist ➔A Study of Barzolvolimab in Patients With Atopic Dermatitis
📍 Cahaba Dermatology & Skin Health Center, LLC — Birmingham, Alabama
View Study & Checklist ➔A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
📍 Kymera Investigative Site — Birmingham, Alabama
View Study & Checklist ➔A Study Evaluating APG777 in Atopic Dermatitis
📍 Investigational Site — Fountain Valley, California
View Study & Checklist ➔A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
📍 The Center for Dermatology Clinical Research — Fremont, California
View Study & Checklist ➔A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis
📍 Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550 — Fountain Hills, Arizona
View Study & Checklist ➔Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)
📍 Cahaba Dermatology Skin Health Center — Birmingham, Alabama
View Study & Checklist ➔A Study Evaluating TRIV-509 in Atopic Dermatitis
📍 Triveni Bio Site #11 — Fountain Valley, California
View Study & Checklist ➔Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
📍 Ctr for Dermatology Clinical Res — Fremont, California
View Study & Checklist ➔A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
📍 Enveda Investigative Site — Encinitas, California
View Study & Checklist ➔Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
📍 UCLA Division of Dermatology — Los Angeles, California
View Study & Checklist ➔A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
📍 Investigational Site — Fountain Valley, California
View Study & Checklist ➔Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
📍 Novartis Investigative Site — Birmingham, Alabama
View Study & Checklist ➔A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
📍 AllerVie Clinical Research — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
📍 Inmagene Site 1 — Lancaster, California
View Study & Checklist ➔Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
📍 First OC Dermatology — Fountain Valley, California
View Study & Checklist ➔Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
📍 Corvus Clinical Trials — South San Francisco, California
View Study & Checklist ➔A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
📍 Allervie Clinical Research — Birmingham, Alabama
View Study & Checklist ➔A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
📍 Atd002 52021 — Oceanside, California
View Study & Checklist ➔A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
📍 Marvel Clinical Research — Huntington Beach, California
View Study & Checklist ➔Cardamom and Topical Roseomonas in Atopic Dermatitis
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔